Comparing COPD Treatment: Nebulizer, Metered Dose Inhaler, and Concomitant Therapy

American Journal of Medicine

Volumn 120, Issue 5, 2007, Pages 435-441

  Tashkin, Donald P ^a   Klein, Gerald L ^b,c   Colman, Shoshana S ^d   Zayed, Hany ^d   Schonfeld, Warren H ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Talecris Biotherapeutics Inc   (United States)

^c UP   (United States)

^d IQVIA   (United States)

^e NONE

Author keywords

COPD; Metered dose inhaler; Nebulizer; Symptom relief

Indexed keywords

IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; NEBULIZER; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ALBUTEROL; BRONCHODILATOR AGENTS; HUMANS; IPRATROPIUM; METERED DOSE INHALERS; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 34247186876     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.07.043     Document Type: Article

References (16)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2005 Update. National Institutes of Health/WHO. Available at: http://www.goldcopd.com/. Accessed August 23, 2005.
2. Celli B.R., MacNee W., Agusti A., et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
3. Gross N., Tashkin D., Miller R., et al. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Respiration 65 (1998) 354-362
4. Tashkin D., Bleecker E., Braun S., et al. Results of a mulitcenter study of nebulized inhalant bronchodilator solutions. Am J Med 100 Suppl 1 (1996) S62-S69
5. 2 agonists in patients with chronic obstructive pulmonary disease. Am J Med 100 Suppl 1 (1996) S40-S48
6. Ikeda A., Nishimura K., Koyama H., et al. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. Chest 107 (1995) 401-405
7. COMBIVENT Inhalation Aerosol Study Group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multi-center trial. Chest 105 (1994) 1411-1419
8. Balzano G., Battiloro R., Biraghi M., et al. Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chnronic airflow obstruction: metered dose inhaler versus jet nebulizer. J Aerosol Med 13 (2000) 25-33
9. Dolovich M.B., Ahrens R.C., Hess D.R., et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines. Chest 127 (2005) 335-371
10. Van Beerendonk I., Mesters I., Mudde A.N., et al. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma 35 (1998) 273-279
11. Crapo R.O., Morris A.H., and Gardner R.M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 123 (1981) 659-664
12. Jones P.W., Quirk F.H., and Baveystock C.M. The St. George's Respiratory Questionnaire. Respir Med 85 Suppl B (1991) 25-31
13. Dahl R., Greefhorst L., Nowak D., et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disesase. Am J Respir Crit Care Med 164 (2001) 778-784
14. Mahler D.A., Ward J., Fierro-Carrion G., et al. Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. COPD 1 (2004) 165-172
15. O'Donnell D.E., Lam M., and Webb K.A. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 (1998) 1557-1565
16. Barta S., Crawford A., and Roberts C. Survey of patients' views of domiciliary nebuliser treatment for chronic lung disease. Respir Med 96 (2002) 375-381